Skip to content

MAIA Biotechnology, Inc.

MAIA· NYSECore metricsCIK 1878313

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -0.97%
Market cap
$62.99M
61.75M shares
Filings
504
$0.00
FY 2024
-$7.18M
Q3 2026N/M FY25 yoy
-$8.02M
Q3 2026N/M FY25 yoy
—
—
—
-$0.12
Q3 2026N/M FY25 yoy
$0.00
Q3 2026
$62.99M
—
—
4.3×
—
—

FY2025 figures · derived

Price

$1.028.93%$0.10past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2024
$0.000FY 2022FY 2023FY 2024
PeriodEndedValueKindSource trail
FY 20242024-12-31$0reported
FY 20232023-12-31$0reported
FY 20222022-12-31$0reported

Pharmaceutical preparations

MAIA Biotechnology, Inc. is the 318th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

MAIA Biotechnology, Inc. · CIK 1878313 · Engraved from SEC EDGAR